Reduction of cPLA2alpha overexpression: an efficient anti-inflammatory therapy for collagen-induced arthritis.

Reduction of cPLA2alpha overexpression: an efficient anti-inflammatory therapy for collagen-induced arthritis.

Cytosolic phospholipase A2alpha (cPLA2) plays an important role in the development of several inflammatory diseases. The aim of the present study is to determine whether inhibition of cPLA2 expression, using specific antisense oligonucleotides against cPLA2 (antisense), is efficient in reducing infl...

Bibliografiset tiedot
Päätekijät:	Raichel, L, Berger, S, Hadad, N, Kachko, L, Karter, M, Szaingurten-Solodkin, I, Williams, R, Feldmann, M, Levy, R
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2008

Samankaltaisia teoksia

Modulation of the activity of cytosolic phospholipase A2α (cPLA2α) by cellular sphingolipids and inhibition of cPLA2α by sphingomyelin[S]
Tekijä: Hiroyuki Nakamura, et al.
Julkaistu: (2010-04-01)

Brain lipid metabolism in the cPLA2 knockout mouse
Tekijä: Thad A. Rosenberger, et al.
Julkaistu: (2003-01-01)

Effect of zinc oxide suspension on the overall filler content of the PLA/ZnO composites and cPLA/ZnO composites
Tekijä: Tan Mei Ai, et al.
Julkaistu: (2023-06-01)

Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons
Tekijä: Vanessa de Jesus De-Paula, et al.
Julkaistu: (2015-11-01)

Mechanical Activation of cPLA2 Impedes Fatty Acid β‐Oxidation in Vein Grafts
Tekijä: Linwei Fan, et al.
Julkaistu: (2025-01-01)

cPLA<sub>2</sub>α Enzyme Inhibition Attenuates Inflammation and Keratinocyte Proliferation
Tekijä: Felicity J. Ashcroft, et al.
Julkaistu: (2020-10-01)

Cytosolic Phospholipase A2(cPLA2) Immunoreactivity Is Elevated in Alzheimer's Disease Brain
Tekijä: Diane T. Stephenson, et al.
Julkaistu: (1996-02-01)

Interleukin 15 primes natural killer cells to kill via NKG2D and cPLA2 and this pathway is active in psoriatic arthritis.
Tekijä: Fangming Tang, et al.
Julkaistu: (2013-01-01)

Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy.
Tekijä: Williams, R, et al.
Julkaistu: (2000)

Highly Potent 2‑Oxoester Inhibitors of Cytosolic Phospholipase A2 (GIVA cPLA2)
Tekijä: Anastasia Psarra, et al.
Julkaistu: (2018-08-01)

A distal enhancer controls cytokine-dependent human cPLA2α gene expression[S]
Tekijä: Justin S. Bickford, et al.
Julkaistu: (2013-07-01)

Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase
Tekijä: Joakim Huber, et al.
Julkaistu: (2006-05-01)

Correction to “Highly Potent 2‑Oxoester Inhibitors of Cytosolic Phospholipase A2 (GIVA cPLA2)”
Tekijä: Anastasia Psarra, et al.
Julkaistu: (2019-06-01)

Involvement of the γ Isoform of cPLA<sub>2</sub> in the Biosynthesis of Bioactive <i>N-</i>Acylethanolamines
Tekijä: Yiman Guo, et al.
Julkaistu: (2021-08-01)

Inhibition of sPLA₂-IIA prevents LPS-induced neuroinflammation by suppressing ERK1/2-cPLA₂α pathway in mice cerebral cortex.
Tekijä: Yanxiao Xiang, et al.
Julkaistu: (2013-01-01)

Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
Tekijä: Ross, SE, et al.
Julkaistu: (1997)

Therapeutic actions of cyclosporine and anti-tumor necrosis factor alpha in collagen-induced arthritis and the effect of combination therapy.
Tekijä: Williams, R, et al.
Julkaistu: (1998)

Structure Activity Relationship and Molecular Docking of Some Quinazolines Bearing Sulfamerazine Moiety as New 3CLpro, cPLA2, sPLA2 Inhibitors
Tekijä: Mohammed Abdalla Hussein, et al.
Julkaistu: (2023-08-01)

Elamipretide alleviates pyroptosis in traumatically injured spinal cord by inhibiting cPLA2-induced lysosomal membrane permeabilization
Tekijä: Haojie Zhang, et al.
Julkaistu: (2023-01-01)

The effects of myelin on macrophage activation are phenotypic specific via cPLA2 in the context of spinal cord injury inflammation
Tekijä: Timothy J. Kopper, et al.
Julkaistu: (2021-03-01)

Inhibition of Cytosolic Phospholipase A2α (cPLA2α) by Medicinal Plants in Relation to Their Phenolic Content
Tekijä: Eva Arnold, et al.
Julkaistu: (2015-08-01)

Formyl Peptide Receptor 2-Dependent cPLA2 and 5-LOX Activation Requires a Functional NADPH Oxidase
Tekijä: Tiziana Pecchillo Cimmino, et al.
Julkaistu: (2024-02-01)

Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2α/ACSL4 signaling pathway
Tekijä: Shuo Xu, et al.
Julkaistu: (2024-01-01)

cPLA2 phosphorylation at serine-515 and serine-505 is required for arachidonic acid release in vascular smooth muscle cells
Tekijä: Zoran Pavicevic, et al.
Julkaistu: (2008-04-01)

TNF-alpha-induced cPLA2 expression via NADPH oxidase/reactive oxygen species-dependent NF-kappaB cascade on human pulmonary alveolar epithelial cells
Tekijä: Chih-Chung Lin, et al.
Julkaistu: (2016-11-01)

Increased Expression and Activity of Brain Cortical cPLA2 Due to Chronic Lipopolysaccharide Administration in Mouse Model of Familial Alzheimer’s Disease
Tekijä: Mikko Gynther, et al.
Julkaistu: (2022-11-01)

Blue light alters cellular lipidome—Light-induced lipidomic changes can be modulated by optogenetically engineered cPLA2α
Tekijä: Chi Zhang, et al.
Julkaistu: (2022-12-01)

Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway
Tekijä: Catherine Malaplate-Armand, et al.
Julkaistu: (2006-07-01)

Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha.
Tekijä: Williams, R
Julkaistu: (2007)

Coptisine ameliorates colitis in mice by modulating cPLA2/TRPM8/CGRP-1 signaling pathways and strengthening intestinal barrier function
Tekijä: Wenbin Wu, et al.
Julkaistu: (2025-03-01)

Alveolar macrophage-derived gVPLA2 promotes ventilator-induced lung injury via the cPLA2/PGE2 pathway
Tekijä: Hanghang Han, et al.
Julkaistu: (2023-12-01)

Effect of Kaempferol on Cyclooxygenase 2 (Cox2) and Cytosolic Phospholipase A2 (cPLA2) Protein Expression in BALB/c Mice
Tekijä: Da Rae Kang, et al.
Julkaistu: (2018-10-01)

Gigantol ameliorates CCl4-induced liver injury via preventing activation of JNK/cPLA2/12-LOX inflammatory pathway
Tekijä: Yaru Xue, et al.
Julkaistu: (2020-12-01)

Suppression of collagen-induced arthritis by continuous administration of IL-4.
Tekijä: Horsfall, A, et al.
Julkaistu: (1997)

Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition
Tekijä: Stijn A.I. Ghesquiere, et al.
Julkaistu: (2005-02-01)

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Tekijä: Williams, R, et al.
Julkaistu: (1992)

Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA).
Tekijä: Marinova-Mutafchieva, L, et al.
Julkaistu: (1997)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
Tekijä: Maini, R, et al.
Julkaistu: (1994)

Elucidating the role of S100A10 in CD8+ T cell exhaustion and HCC immune escape via the cPLA2 and 5-LOX axis
Tekijä: Ganggang Wang, et al.
Julkaistu: (2024-08-01)

Sulforaphane attenuates platelet granule secretion through down-regulating glycoprotein VI-mediated p38 MAPK/cPLA2 signaling pathway
Tekijä: Xinhui Huang, et al.
Julkaistu: (2023-12-01)